A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings

Journal of General Internal Medicine

Volumn 30, Issue 6, 2015, Pages 810-816

  Lewis, Carmen L ^a   Adams, Jared ^c,d   Tai Seale, Ming ^c   Huang, Qiwen ^c   Knowles, Sarah B ^c   Nielsen, Matthew E ^b   Pignone, Michael P ^b,i   Walter, Louise C ^e,f   Frosch, Dominick L ^c,g,h  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Division of Geriatrics   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g GORDON AND BETTY MOORE FOUNDATION   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

cancer prevention; early detection of cancer; medical decision making; prostate cancer; prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ADULT; ARTICLE; CANCER SCREENING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIMARY MEDICAL CARE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; AGED; BLOOD; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; MIDDLE AGED; MULTICENTER STUDY; PRIMARY HEALTH CARE; PROCEDURES; PROSTATIC NEOPLASMS;

AGED; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84929836715     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3214-9     Document Type: Article

References (25)

1. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;10, CD001431.
2. Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/prostate/basic_info/screening.htm. Accessed Jan 23 2015.
3. National Cancer Institute FactSheet: Prostate-Specific Antigen (PSA) Test. National Cancer Instititute. 2012. http://www.cancer.gov/cancertopics/factsheet/detection/PSA. Accessed Jan 23 2015.
4. American Cancer Society recommendations for prostate cancer early detection. American Cancer Society. 2012. http://www.cancer.org/cancer/prostatecancer/moreinformation/prostatecancerearlydetection/prostate-cancer-early-detection-acs-recommendations. Accessed Jan 23 2015.
5. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013;190(2):419–26.
6. Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007;33(5):428–34.
7. Evans R, Edwards A, Brett J, Bradburn M, Watson E, Austoker J, et al. Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations. Patient Educ Counsel. 2005;58(1):13–26.
8. Taylor KL, Williams RM, Davis K, Luta G, Penek S, Barry S, et al. Decision Making in Prostate Cancer Screening Using Decision Aids vs Usual Care: A Randomized Clinical Trial. JAMA internal medicine. 2013.
9. Brackett C, Kearing S, Cochran N, Tosteson AN, Blair BW. Strategies for distributing cancer screening decision aids in primary care. Patient Educ Counsel. 2010;78(2):166–8.
10. Miller KM, Brenner A, Griffith JM, Pignone MP, Lewis CL. Promoting decision aid use in primary care using a staff member for delivery. Patient Educ Counsel. 2012;86(2):189–94.
11. Driscoll DL, Rupert DJ, Golin CE, McCormack LA, Sheridan SL, Welch BM, et al. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions. Am J Prev Med. 2008;35(2):87–94.
12. Frosch DL, Kaplan RM, Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001;16(6):391–8.
13. Frosch DL, Kaplan RM, Felitti VJ. A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med. 2003;18(10):781–7.
14. Radosevich DM, Partin MR, Nugent S, Nelson D, Flood AB, Holtzman J, et al. Measuring patient knowledge of the risks and benefits of prostate cancer screening. Patient Educ Counsel. 2004;54(2):143–52.
15. Frosch DL, Bhatnagar V, Tally S, Hamori CJ, Kaplan RM. Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening. Arch Intern Med. 2008;168(4):363–9.
16. Brawley OW, Ankerst DP, Thompson IM. Screening for prostate cancer. CA: a cancer journal for clinicians. 2009;59(4):264–73.
17. Lewis CL, Brenner AT, Griffith JM, Pignone MP. The uptake and effect of a mailed multi-modal colon cancer screening intervention: a pilot controlled trial. Implementation science. 2008;3:32.
18. Lewis CL, Pignone MP. Promoting informed decision-making in a primary care practice by implementing decision aids. N C Med J. 2009;70(2):136–9.
19. Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013;158(10):761–9.
20. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening. CA: a cancer journal for clinicians. 2010;60(2):99–119.
21. Moyer VA. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012;157(2):120–34.
22. Partin MR, Nelson D, Radosevich D, Nugent S, Flood AB, Dillon N, et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med. 2004;19(8):835–42.
23. Elwyn G, Lloyd A, Joseph-Williams N, Cording E, Thomson R, Durand MA, et al. Option Grids: shared decision making made easier. Patient Educ Counsel. 2013;90(2):207–12.
24. Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Publ Health. 2003;93(8):1261–7.
25. Wolf AMD, Wender RC, Etzioni RB, Thompson IM, D’Amico AV, Volk RJ, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA: a cancer journal for clinicians. 2010;60(2):70–98.